Clinical implications of the proposed ICD-11 PTSD diagnostic criteria.


Journal

Psychological medicine
ISSN: 1469-8978
Titre abrégé: Psychol Med
Pays: England
ID NLM: 1254142

Informations de publication

Date de publication:
02 2019
Historique:
pubmed: 15 5 2018
medline: 24 4 2020
entrez: 15 5 2018
Statut: ppublish

Résumé

Projected changes to post-traumatic stress disorder (PTSD) diagnostic criteria in the upcoming International Classification of Diseases (ICD)-11 may affect the prevalence and severity of identified cases. This study examined differences in rates, severity, and overlap of diagnoses using ICD-10 and ICD-11 PTSD diagnostic criteria during consecutive assessments of recent survivors of traumatic events. The study sample comprised 3863 survivors of traumatic events, evaluated in 11 longitudinal studies of PTSD. ICD-10 and ICD-11 diagnostic rules were applied to the Clinician-Administered PTSD Scale (CAPS) to derive ICD-10 and ICD-11 diagnoses at different time intervals between trauma occurrence and 15 months. The ICD-11 criteria identified fewer cases than the ICD-10 across assessment intervals (range -47.09% to -57.14%). Over 97% of ICD-11 PTSD cases met concurrent ICD-10 PTSD criteria. PTSD symptom severity of individuals identified by the ICD-11 criteria (CAPS total scores) was 31.38-36.49% higher than those identified by ICD-10 criteria alone. The latter, however, had CAPS scores indicative of moderate PTSD. ICD-11 was associated with similar or higher rates of comorbid mood and anxiety disorders. Individuals identified by either ICD-10 or ICD-11 shortly after traumatic events had similar longitudinal course. This study indicates that significantly fewer individuals would be diagnosed with PTSD using the proposed ICD-11 criteria. Though ICD-11 criteria identify more severe cases, those meeting ICD-10 but not ICD-11 criteria remain in the moderate range of PTSD symptoms. Use of ICD-11 criteria will have critical implications for case identification in clinical practice, national reporting, and research.

Sections du résumé

BACKGROUND
Projected changes to post-traumatic stress disorder (PTSD) diagnostic criteria in the upcoming International Classification of Diseases (ICD)-11 may affect the prevalence and severity of identified cases. This study examined differences in rates, severity, and overlap of diagnoses using ICD-10 and ICD-11 PTSD diagnostic criteria during consecutive assessments of recent survivors of traumatic events.
METHODS
The study sample comprised 3863 survivors of traumatic events, evaluated in 11 longitudinal studies of PTSD. ICD-10 and ICD-11 diagnostic rules were applied to the Clinician-Administered PTSD Scale (CAPS) to derive ICD-10 and ICD-11 diagnoses at different time intervals between trauma occurrence and 15 months.
RESULTS
The ICD-11 criteria identified fewer cases than the ICD-10 across assessment intervals (range -47.09% to -57.14%). Over 97% of ICD-11 PTSD cases met concurrent ICD-10 PTSD criteria. PTSD symptom severity of individuals identified by the ICD-11 criteria (CAPS total scores) was 31.38-36.49% higher than those identified by ICD-10 criteria alone. The latter, however, had CAPS scores indicative of moderate PTSD. ICD-11 was associated with similar or higher rates of comorbid mood and anxiety disorders. Individuals identified by either ICD-10 or ICD-11 shortly after traumatic events had similar longitudinal course.
CONCLUSIONS
This study indicates that significantly fewer individuals would be diagnosed with PTSD using the proposed ICD-11 criteria. Though ICD-11 criteria identify more severe cases, those meeting ICD-10 but not ICD-11 criteria remain in the moderate range of PTSD symptoms. Use of ICD-11 criteria will have critical implications for case identification in clinical practice, national reporting, and research.

Identifiants

pubmed: 29754591
pii: S0033291718001101
doi: 10.1017/S0033291718001101
pmc: PMC6331687
doi:

Types de publication

Comparative Study Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

483-490

Subventions

Organisme : NIMH NIH HHS
ID : R01 MH101227
Pays : United States

Références

J Clin Psychiatry. 1998;59 Suppl 20:22-33;quiz 34-57
pubmed: 9881538
J Trauma Stress. 2008 Aug;21(4):377-84
pubmed: 18720390
Br J Psychiatry. 2008 May;192(5):376-83
pubmed: 18450664
J Trauma Stress. 2013 Oct;26(5):560-2
pubmed: 24151003
Eur J Psychotraumatol. 2016 Jan 21;7:29700
pubmed: 26800660
BMC Psychiatry. 2016 May 12;16:140
pubmed: 27176723
Depress Anxiety. 2001;13(3):132-56
pubmed: 11387733
Int J Neuropsychopharmacol. 2008 May;11(3):365-72
pubmed: 17971262
BMC Psychiatry. 2014 Mar 28;14:92
pubmed: 24679046
Eur J Psychotraumatol. 2013 Dec 03;4:
pubmed: 24312721
J Trauma Stress. 1995 Jan;8(1):75-90
pubmed: 7712061
Eur J Psychotraumatol. 2010;1:
pubmed: 22893801
Lancet. 2013 May 11;381(9878):1683-5
pubmed: 23583019
Am J Psychiatry. 2001 Aug;158(8):1248-51
pubmed: 11481158
Eur J Psychotraumatol. 2013 May 15;4:
pubmed: 23687563
Depress Anxiety. 2014 Jun;31(6):494-505
pubmed: 24894802
Arch Gen Psychiatry. 2012 Feb;69(2):166-76
pubmed: 21969418
J Med Internet Res. 2013 Aug 13;15(8):e165
pubmed: 23942480
JAMA Psychiatry. 2013 Aug;70(8):839-46
pubmed: 23784521
Soc Psychiatry Psychiatr Epidemiol. 2009 Apr;44(4):333-40
pubmed: 18818856
J Trauma Stress. 2009 Dec;22(6):540-8
pubmed: 19924822
JAMA Psychiatry. 2016 Jul 1;73(7):750-2
pubmed: 27224895
Psychiatry Res. 2016 Jun 30;240:226-233
pubmed: 27124207
J Trauma Stress. 2013 Oct;26(5):557-9
pubmed: 24151002
BMC Psychiatry. 2017 May 22;17(1):191
pubmed: 28532449
Am J Psychiatry. 2000 Feb;157(2):255-61
pubmed: 10671396

Auteurs

Anna C Barbano (AC)

Department of Psychiatry,New York University School of Medicine,1 Park Avenue, New York, NY 10016,USA.

Willem F van der Mei (WF)

Department of Psychiatry,New York University School of Medicine,1 Park Avenue, New York, NY 10016,USA.

Richard A Bryant (RA)

School of Psychology, University of New South Wales,Sydney, NSW, 2052,Australia.

Douglas L Delahanty (DL)

Department of Psychological Sciences,Kent State University,144 Kent Hall, Kent, OH 44242,USA.

Terri A deRoon-Cassini (TA)

Department of Surgery,Medical College of Wisconsin,9200 W. Wisconsin Ave, Milwaukee, WI 53226,USA.

Yutaka J Matsuoka (YJ)

Division of Health Care Research,Center for Public Health Sciences, National Cancer Center Japan,5-1-1 Tsukiji, Chou-ku, Tokyo 104-0045,Japan.

Miranda Olff (M)

Department of Psychiatry,Academic Medical Center, University of Amsterdam,Meibergdreef 9,1105 AZ Amsterdam,The Netherlands.

Wei Qi (W)

Department of Psychiatry,New York University School of Medicine,1 Park Avenue, New York, NY 10016,USA.

Andrew Ratanatharathorn (A)

Department of Epidemiology,Columbia University Mailman School of Public Health,722 W 168th St., New York, NY 10032,USA.

Ulrich Schnyder (U)

Department of Psychiatry and Psychotherapy,University Hospital Zurich,PO Box 1931, Lenggstrasse 31, 8032,Zürich/Switzerland.

Soraya Seedat (S)

Department of Psychiatry,Stellenbosch University,Private Bag X1, Matieland, 7602, Stellenbosch,South Africa.

Ronald C Kessler (RC)

Department of Health Care Policy,Harvard Medical School,180 Longwood Ave, Boston, MA 02115,USA.

Karestan C Koenen (KC)

Department of Epidemiology,Harvard T.H. Chan School of Public Health,Kresge 505, 677 Huntington Avenue, Kresge Building, Boston, MA 02115,USA.

Arieh Y Shalev (AY)

Department of Psychiatry,New York University School of Medicine,1 Park Avenue, New York, NY 10016,USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH